Thank you, Madam Speaker. I’d like to follow up with my earlier questions but broaden the category to a discussion of the issues that this government has or should have with Ottawa. The first one I’d like to discuss is the Canada-European Union Free Trade Agreement. Noting that Europe is now demanding extension of brand use names of drug patents and along with extension of the time that the brand name companies can keep the recipes for those drugs secret so that generic drugs cannot be produced, this would drive up the cost of drugs. Premiers across the country have been reacting and, according to Premier Clark in BC, writing Ottawa objecting to this. Ottawa so far is silent on the issue. Has the Premier written Ottawa to object to that demand from Europe in these free trade discussions of which we’re a part?